control group:valsartan
Sponsors
Department of Nephrology, Affiliated Hospital of Nantong University, Children's Hospital, Zhejiang University School of Medicine, Affiliated Hospital of Changchun University of Chinese Medicine, the First Affiliated Hospital of Anhui University of Chinese Medicine, Shanghai Dong Fang Hospital
Conditions
Children with purpura nephritisChronic Kidney DiseaseDiabetic NephropathyPeritoneal dialysisPrimary IgA nephropathy
Early Phase 1
A single center randomized controlled clinical study on the treatment of Children with Purpura nephritis with Huai-Qi-Huang Granules
RecruitingChiCTR2000039700
Start: 2020-11-06Updated: 2021-02-16
A single center randomized controlled clinical study on the treatment of Children with Purpura nephritis with Huai-Qi-Huang Granules
RecruitingITMCTR2100004424
Start: 2020-11-06Updated: 2023-02-20
Phase 1
Clinical effect and mechanism of Shenan decoction in the treatment of diabetic nephropathy:A Randomized Controlled Clinical trial study Protocol
Active, not recruitingChiCTR2100048078
Start: 2021-08-21Updated: 2022-03-07
Clinical effect and mechanism of Shenan decoction in the treatment of diabetic nephropathy:A Randomized Controlled Clinical trial study Protocol
Active, not recruitingITMCTR2100005004
Start: 2021-08-21Updated: 2023-02-20
Phase 4
Effect of Sacubitril/Valsartan on cardiac function and residual renal function in peritoneal dialysis patients with heart failure
RecruitingChiCTR2000039561
Start: 2020-11-01Updated: 2021-02-08
Protective effect of Sacubitril/Valsartan on residual renal function in peritoneal dialysis patients: a multicenter, prospective, open label, randomized controlled study
RecruitingChiCTR2100054733
Start: 2021-12-20Updated: 2022-12-05